Dicerna Pharma (DRNA) Tops Q2 EPS by 9c
Dicerna Pharma (NASDAQ: DRNA) reported Q2 EPS of ($0.75), $0.09 better than the analyst estimate of ($0.84).
For earnings history and earnings-related data on Dicerna Pharma (DRNA) click here.
Dicerna Pharma (NASDAQ: DRNA) reported Q2 EPS of ($0.75), $0.09 better than the analyst estimate of ($0.84).
For earnings history and earnings-related data on Dicerna Pharma (DRNA) click here.